Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung



Rating:

Share or cite this content

Citations should be made in the following way:
N. Oikonomou, A. Thanasopoulou, A. Kotanidou, G.D. Prestwich, V. Aidinis (Salt Lake City, United States of America). Oral presentation: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation. Lung Science Conference 2010 - Biology of gene-environment interactions in the lung

Member's Comments

No comment yet.

Related content which might interest you: LSC 2010 Abstract: Genetic or pharmacologic inhibition of ATX stimulates LPS-induced pulmonary inflammation Source: Annual Congress 2010 - Acute lung injury: barrier properties and leukocyte activation Year: 2010 cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Oral presentation: Sphingosine-1-phosphate administration in vivo induces airway inflammation and hypereactivity in a IgE-dependent manner Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Effect of curcumin on LPS-induced neutrophil activation and acute lung injury Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012 Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Inhibition by roflumilast vs cilomilast of pulmonary leukocyte accumulation and TNFα release in a rat model of LPS-induced pulmonary neutrophilia Source: Eur Respir J 2003; 22: Suppl. 45, 107s Year: 2003 Sirtuins inhibition modulates endotoxin-induced lung inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 Effect of doxofylline on LPS-induced leukocyte migration to the lung Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008 Inhibition of HGF secretion by pulmonary fibroblasts from IPF: involvement of PGE2 Source: Eur Respir J 2003; 22: Suppl. 45, 8s Year: 2003 Inhibition of LPS-induced cytokine/chemokine production from human lung macrophages by roflumilast is enabled by autocrine PGE2 Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma Source: Eur Respir J 2010; 35: 750-756 Year: 2010 PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced pulmonary fibrosis by inhibition of multiple pro-inflammatory/fibrotic key mediators Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Intrabronchial activated protein C enhances lipopolysaccharide-induced pulmonary responses Source: Eur Respir J 2013; 42: 188-197 Year: 2013 Chronic nitric oxide inhibition modulates inflammatory cells apoptosis induced by dexamethasone in guinea pigs with chronic airway inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 368s Year: 2005 Oral Presentation: Angiostatin inhibits neutrophil migration and activation Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Iron overload modulates LPS-induced lung inflammation: Implications for sensitive populations Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010